David Castel

7PUBLICATIONS
78CO-AUTHORS
Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMedical infection agents (incl. prions)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 27, 2026
Phase I/II Study of the PARP Inhibitor Olaparib and Irinotecan in Children and Young Adults with Recurrent/Refractory Malignancies: Arm D of the AcSé-ESMART Trial.

Susanne A Gatz, Pablo Berlanga, Gwénaël Le Teuff

|Sep 05, 2024
Glioma oncogenesis in the Constitutional mismatch repair deficiency (CMMRD) syndrome.

Lea Guerrini-Rousseau, Jane Merlevede, Philippe Denizeau

|Nov 02, 2023
iPS-cell-derived microglia promote brain organoid maturation via cholesterol transfer.

Dong Shin Park, Tatsuya Kozaki, Satish Kumar Tiwari

|Sep 13, 2023
Diffuse midline glioma invasion and metastasis rely on cell-autonomous signaling.

Marco Bruschi, Lilia Midjek, Yassine Ajlil

|Mar 11, 2018
Small-RNA sequencing identifies dynamic microRNA deregulation during skeletal muscle lineage progression.

David Castel, Meryem B Baghdadi, Sébastien Mella

Pageof 2